We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.06B
AUM Growth
+$11.1M
Cap. Flow
-$39M
Cap. Flow %
-3.69%
Top 10 Hldgs %
18.29%
Holding
2,111
New
638
Increased
394
Reduced
467
Closed
537

Sector Composition

Rank Sector Weight
1 Technology 18.22%
2 Healthcare 13.36%
3 Communication Services 10.32%
4 Consumer Discretionary 7.52%
5 Industrials 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
A icon
926
Agilent Technologies
A
$39.3B
$60K 0.01%
+1,005
New +$57.2K
HIG icon
927
Hartford Financial Services
HIG
$38.9B
$60K 0.01%
+1,135
New +$56.2K
MATV icon
928
Mativ Holdings
MATV
$507M
$60K 0.01%
1,600
+648
+68% +$25.6K
NVR icon
929
NVR
NVR
$16.8B
$60K 0.01%
25
-40
-62% -$90.2K
RAMP icon
930
LiveRamp
RAMP
$2.3B
$60K 0.01%
+2,310
New +$62.8K
SAIC icon
931
Saic
SAIC
$5.09B
$60K 0.01%
870
+170
+24% +$12.5K
SAVE
932
DELISTED
Spirit Airlines, Inc.
SAVE
$60K 0.01%
+1,165
New +$63.7K
GBT
933
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
$60K 0.01%
2,200
HY icon
934
Hyster-Yale Materials Handling
HY
$629M
$59K 0.01%
837
-3,063
-79% -$209K
TRN icon
935
CALL
Trinity Industries
TRN
$2.55B
$59K 0.01%
+2,917
New +$56K
ITCI
936
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$59K 0.01%
4,715
-4,485
-49% -$52K
OME
937
DELISTED
Omega Protein
OME
$59K 0.01%
3,300
-6,200
-65% -$116K
SVA
938
DELISTED
Sinovac Biotech, Ltd
SVA
$59K 0.01%
+8,800
New +$48.2K
GEN icon
939
Gen Digital
GEN
$16.9B
$58K 0.01%
2,055
-9,435
-82% -$285K
IMAX icon
940
IMAX
IMAX
$2.81B
$58K 0.01%
+2,627
New +$73.7K
KEY icon
941
KeyCorp
KEY
$24.8B
$58K 0.01%
3,100
-4,128
-57% -$74.7K
SYNT
942
DELISTED
Syntel Inc
SYNT
$58K 0.01%
3,400
-16,100
-83% -$279K
GECC icon
943
Great Elm Capital Corp
GECC
$73.5M
$57K 0.01%
895
+361
+68% +$23.4K
TER icon
944
Teradyne
TER
$63.1B
$57K 0.01%
1,900
-1,000
-34% -$33.6K
VTVT icon
945
vTv Therapeutics
VTVT
$126M
$57K 0.01%
285
USAP
946
DELISTED
Universal Stainless & Alloy
USAP
$57K 0.01%
+2,933
New +$52.8K
EIGR
947
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$57K 0.01%
+240
New +$54.5K
ARNA
948
DELISTED
Arena Pharmaceuticals Inc
ARNA
$57K 0.01%
3,400
-6,140
-64% -$84.2K
DKS icon
949
CALL
Dick's Sporting Goods
DKS
$18B
$56K 0.01%
+1,400
New +$63.1K
MAN icon
950
ManpowerGroup
MAN
$2.55B
$56K 0.01%
500
-747
-60% -$77.1K

Similar funds

Prelude Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Prelude Capital Management held 2,111 positions worth $1.06B, up 1.1% from $1.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Prelude Capital Management withdrew a net $39M in Q2 2017, closing 537 positions and reducing 467 holdings. Its most notable exit was The WhiteWave Foods Company, an estimated $13.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 11% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Prelude Capital Management opened a new position in Altaba Inc worth $16.4M.

  • Prelude Capital Management's largest Q2 2017 buy was Altaba Inc: 301,001 shares worth $16.4M.
  • Prelude Capital Management added most to CR Bard Inc. in Q2 2017, an estimated $24.5M increase.
  • Prelude Capital Management's biggest Q2 2017 reduction was T-Mobile US, cutting an estimated $9.34M.
  • Prelude Capital Management fully exited The WhiteWave Foods Company in Q2 2017, selling an estimated $13.3M.
  • Prelude Capital Management's ten largest holdings make up 18% of its $1.06B portfolio in Q2 2017.
  • Prelude Capital Management opened 638 new positions and closed 537 in Q2 2017.
  • Prelude Capital Management's portfolio value rose 1.1% quarter-over-quarter to $1.06B.

Based on Prelude Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.